Inventor
FALB DEAN
US23 patents
⚠️ This page may combine multiple inventors who share the name “FALB DEAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNLOGIC OPERATING CO INC
19 patentsUS11471494B2Oct 18, 2022
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
SYNLOGIC OPERATING CO INC7 citations84
US11291693B2Apr 5, 2022
Bacteria engineered to treat metabolic diseases
SYNLOGIC OPERATING CO INC9 citations84
US11060073B2Jul 13, 2021
Bacteria engineered to treat diseases associated with hyperammonemia
SYNLOGIC OPERATING CO INC5 citations83
US10933102B2Mar 2, 2021
Bacteria engineered to treat a disease or disorder
SYNLOGIC OPERATING CO INC7 citations83
US10610546B2Apr 7, 2020
Bacteria engineered to reduce hyperphenylalaninemia
SYNLOGIC OPERATING CO INC7 citations83
US10273489B2Apr 30, 2019
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
SYNLOGIC OPERATING CO INC12 citations83
US10195234B2Feb 5, 2019
Bacteria engineered to reduce hyperphenylalaninemia
SYNLOGIC OPERATING CO INC6 citations83
US11723932B2Aug 15, 2023
Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
SYNLOGIC OPERATING CO INC5 citations74
US11618894B2Apr 4, 2023
Bacteria engineered to reduce hyperphenylalaninemia
SYNLOGIC OPERATING CO INC5 citations74
US11879123B2Jan 23, 2024
Bacteria for the treatment of disorders
SYNLOGIC OPERATING CO INC4 citations71
US12409195B2Sep 9, 2025
Bacteria engineered to reduce hyperphenylalaninemia
SYNLOGIC OPERATING CO INC0 citations62
US11845964B2Dec 19, 2023
Bacteria engineered to treat diseases associated with hyperammonemia
SYNLOGIC OPERATING CO INC0 citations62
US11685925B2Jun 27, 2023
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
SYNLOGIC OPERATING CO INC0 citations62
US11384359B2Jul 12, 2022
Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
SYNLOGIC OPERATING CO INC0 citations62
US11896627B2Feb 13, 2024
Bacteria engineered to treat metabolic diseases
SYNLOGIC OPERATING CO INC0 citations60
US12545886B2Feb 10, 2026
Bacteria for the treatment of disorders
SYNLOGIC OPERATING CO INC0 citations59
US11273184B2Mar 15, 2022
Bacteria engineered to treat disorders in which oxalate is detrimental
SYNLOGIC OPERATING CO INC0 citations54
US11883439B2Jan 30, 2024
Bacteria engineered to treat a disease or disorder
SYNLOGIC OPERATING CO INC0 citations51
US11439673B2Sep 13, 2022
Bacteria engineered to treat liver disease
SYNLOGIC OPERATING CO INC0 citations51
SYNLOGIC INC
4 patentsUS9889164B2Feb 13, 2018
Bacteria engineered to treat a disease or disorder
SYNLOGIC INC27 citations93
US9688967B2Jun 27, 2017
Bacteria engineered to treat diseases associated with hyperammonemia
SYNLOGIC INC36 citations93
US9487764B2Nov 8, 2016
Bacteria engineered to treat diseases associated with hyperammonemia
SYNLOGIC INC31 citations93
US9943555B2Apr 17, 2018
Bacteria engineered to reduce hyperphenylalaninemia
SYNLOGIC INC5 citations82